Obesity Drug Prices Drop
This is a Canada news story, published by ABC News, that relates primarily to Zepbound news.
Canada news
For more Canada news, you can click here:
more Canada newsZepbound news
For more Zepbound news, you can click here:
more Zepbound newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsABC News news
For more news from ABC News, you can click here:
more news from ABC NewsAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Obesity drug prices. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest obesity medications news, obesity treatment coverage news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
popular obesity treatments WegovyABC News
•Health
Health
Obesity drug prices are dropping, but getting a steady supply remains a challenge
83% Informative
Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity.
The medications still amount to around $500 per month for those without insurance — out of reach for many patients.
Doctors say the situation forces them to get creative in treating patients, but there’s hope that prices may fall more in the future.
Both companies are developing pill versions of their treatments.
Some patients save as much as 15% by getting their doses shipped from a pharmacy in Canada .
Younglove says competition like this, plus the introduction of pill versions, will pressure U.S. prices.
“I think price wars are going to drive it down,” she says.
VR Score
87
Informative language
85
Neutral language
73
Article tone
semi-formal
Language
English
Language complexity
44
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
6
Source diversity
1
Affiliate links
no affiliate links